Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Pfizer : Keeps Quarterly Cash Dividend at $0.39 a Share, Payable Dec. 6 to Shareholders of Record Nov. 5

09/23/2021 | 03:51pm EDT


© MT Newswires 2021
All news about PFIZER, INC.
03:36pMODERNA : U.S. administers over 411 mln doses of COVID-19 vaccines - CDC
RE
02:54pPFIZER WILL SHIP MILLIONS OF VACCINE : Trudeau
AQ
02:10pCOVID-19 VACCINE : CDC panel discusses booster rollout
AQ
02:03pCONSISTENT COMMUNICATION NEEDED FOR : experts
AQ
01:31pMODERNA : U.S. CDC advisers weigh Moderna, J&J COVID-19 vaccine boosters, mix-and-match sh..
RE
12:48pPFIZER : California officials prepare to vaccinate children age 5-11
AQ
12:48pBIONTECH : Shares Rise After Data Shows Efficacy of COVID-19 Vaccine's Booster Dose
MT
12:44pMODERNA : U.S. CDC advisers weigh Moderna, J&J COVID-19 vaccine boosters, mix-and-match sh..
RE
11:26aCanada, Pfizer Strike Deal on Pediatric Vaccine Doses
DJ
11:06aPFIZER : Close to 7,000 Vaccinated On First Day of Teen Inoculation Drive
AQ
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2021 81 557 M - -
Net income 2021 18 627 M - -
Net Debt 2021 29 307 M - -
P/E ratio 2021 12,6x
Yield 2021 3,69%
Capitalization 240 B 240 B -
EV / Sales 2021 3,30x
EV / Sales 2022 3,76x
Nbr of Employees 78 500
Free-Float 59,3%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | PFE | US7170811035 | MarketScreener
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Last Close Price 42,80 $
Average target price 45,72 $
Spread / Average Target 6,83%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.14.34%239 966
JOHNSON & JOHNSON4.07%431 148
ROCHE HOLDING AG13.98%333 101
NOVO NORDISK A/S56.26%238 738
ELI LILLY AND COMPANY44.35%220 952
MERCK & CO., INC.-0.89%205 219